Shl Medical
Shl Medical, a leading name in the medical device industry, is headquartered in Switzerland (CH) and operates extensively across Europe and North America. Founded in 1985, the company has established itself as a pioneer in the development and manufacturing of innovative drug delivery systems, particularly in the fields of injectable devices and auto-injectors. Shl Medical's core offerings include advanced pen injectors and wearable delivery systems, distinguished by their user-centric design and precision engineering. With a commitment to quality and safety, the company has achieved significant milestones, including ISO certifications and partnerships with major pharmaceutical firms. Recognised for its expertise and reliability, Shl Medical continues to strengthen its market position, contributing to improved patient outcomes worldwide.
DitchCarbon Score
How does Shl Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shl Medical's score of 46 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shl Medical's reported carbon emissions
In 2023, SHL Medical reported total carbon emissions of approximately 290,355,000 kg CO2e, a slight decrease from about 298,110,000 kg CO2e in 2022. The emissions breakdown includes Scope 1 emissions of about 43,271,000 kg CO2e, Scope 2 emissions of approximately 440,000 kg CO2e, and significant Scope 3 emissions totalling around 246,644,000 kg CO2e. The Scope 3 emissions encompass various categories, with purchased goods and services contributing about 125,723,000 kg CO2e. SHL Medical has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Additionally, the company targets a reduction of at least 51.6% in Scope 3 emissions per million units sold within the same timeframe. These targets align with the Science Based Targets Initiative (SBTi) and are designed to support global efforts to limit temperature rise to 1.5°C. Overall, SHL Medical's commitment to reducing its carbon footprint reflects a proactive approach to sustainability within the healthcare equipment and supplies sector, positioning the company as a responsible player in addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 42,973,000 | 00,000,000 |
| Scope 2 | 633,000 | 000,000 |
| Scope 3 | 254,504,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shl Medical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
